Copyright
©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 105290
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.105290
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.105290
Table 5 The pharmacotherapy options for pediatric functional neurological disorder
Medication class | Common medications | Indications |
Selective serotonin reuptake inhibitors | Fluoxetine, Sertraline, Citalopram | Anxiety, depression, obsessive-compulsive disorder |
Serotonin-norepinephrine reuptake inhibitors | Venlafaxine, duloxetine | Anxiety, depression, chronic pain |
Antiepileptic drugs | Gabapentin, pregabalin | Neuropathic pain, severe somatic symptoms |
Benzodiazepines | Lorazepam, clonazepam | Acute anxiety, severe stress, non-epileptic seizures (short-term use) |
Melatonin and sedative-hypnotics | Melatonin, zolpidem | Sleep disturbances, insomnia |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Bediwy EA, Elbeltagi R. Unraveling functional neurological disorder in pediatric populations: A systematic review of diagnosis, treatment, and outcomes. World J Clin Pediatr 2025; 14(3): 105290
- URL: https://www.wjgnet.com/2219-2808/full/v14/i3/105290.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.105290